Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2014

01-04-2014 | Preclinical Study

Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures

Authors: Katherine Drews-Elger, Joeli A. Brinkman, Philip Miller, Sanket H. Shah, J. Chuck Harrell, Thiago G. da Silva, Zheng Ao, Amy Schlater, Diana J. Azzam, Kathleen Diehl, Dafydd Thomas, Joyce M. Slingerland, Charles M. Perou, Marc E. Lippman, Dorraya El-Ashry

Published in: Breast Cancer Research and Treatment | Issue 3/2014

Login to get access

Abstract

Our goal was to establish primary cultures from dissociation of breast tumors in order to provide cellular models that may better recapitulate breast cancer pathogenesis and the metastatic process. Here, we report the characterization of six cellular models derived from the dissociation of primary breast tumor specimens, referred to as “dissociated tumor (DT) cells.” In vitro, DT cells were characterized by proliferation assays, colony formation assays, protein, and gene expression profiling, including PAM50 predictor analysis. In vivo, tumorigenic and metastatic potential of DT cultures was assessed in NOD/SCID and NSG mice. These cellular models differ from recently developed patient-derived xenograft models in that they can be used for both in vitro and in vivo studies. PAM50 predictor analysis showed DT cultures similar to their paired primary tumor and as belonging to the basal and Her2-enriched subtypes. In vivo, three DT cultures are tumorigenic in NOD/SCID and NSG mice, and one of these is metastatic to lymph nodes and lung after orthotopic inoculation into the mammary fat pad, without excision of the primary tumor. Three DT cultures comprised of cancer-associated fibroblasts (CAFs) were isolated from luminal A, Her2-enriched, and basal primary tumors. Among the DT cells are those that are tumorigenic and metastatic in immunosuppressed mice, offering novel cellular models of ER-negative breast cancer subtypes. A group of CAFs provide tumor subtype-specific components of the tumor microenvironment (TME). Altogether, these DT cultures provide closer-to-primary cellular models for the study of breast cancer pathogenesis, metastasis, and TME.
Literature
1.
go back to reference Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983–3988PubMedCentralPubMedCrossRef Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983–3988PubMedCentralPubMedCrossRef
2.
go back to reference Amano H, Hayashi I, Endo H, Kitasato H, Yamashina S, Maruyama T et al (2003) Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med 197:221–232PubMedCentralPubMedCrossRef Amano H, Hayashi I, Endo H, Kitasato H, Yamashina S, Maruyama T et al (2003) Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med 197:221–232PubMedCentralPubMedCrossRef
3.
go back to reference Augsten M, Hagglof C, Olsson E, Stolz C, Tsagozis P, Levchenko T et al (2009) CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth. Proc Natl Acad Sci USA 106:3414–3419PubMedCentralPubMedCrossRef Augsten M, Hagglof C, Olsson E, Stolz C, Tsagozis P, Levchenko T et al (2009) CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth. Proc Natl Acad Sci USA 106:3414–3419PubMedCentralPubMedCrossRef
4.
go back to reference Bastien RR, Rodriguez-Lescure A, Ebbert MT, Prat A, Munarriz B, Rowe L et al (2012) PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers. BMC Med Genomics 5:44PubMedCentralPubMedCrossRef Bastien RR, Rodriguez-Lescure A, Ebbert MT, Prat A, Munarriz B, Rowe L et al (2012) PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers. BMC Med Genomics 5:44PubMedCentralPubMedCrossRef
5.
go back to reference Battula VL, Evans KW, Hollier BG, Shi Y, Marini FC, Ayyanan A et al (2010) Epithelial–mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells 28:1435–1445PubMedCentralPubMedCrossRef Battula VL, Evans KW, Hollier BG, Shi Y, Marini FC, Ayyanan A et al (2010) Epithelial–mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells 28:1435–1445PubMedCentralPubMedCrossRef
6.
go back to reference Bayliss J, Hilger A, Vishnu P, Diehl K, El-Ashry D (2007) Reversal of the estrogen receptor negative phenotype in breast cancer and restoration of antiestrogen response. Clin Cancer Res 13:7029–7036PubMedCrossRef Bayliss J, Hilger A, Vishnu P, Diehl K, El-Ashry D (2007) Reversal of the estrogen receptor negative phenotype in breast cancer and restoration of antiestrogen response. Clin Cancer Res 13:7029–7036PubMedCrossRef
7.
go back to reference Bayraktar UD, Kim TK, Drews-Elger K, Benjamin C, El-Ashry D, Wieder E et al (2011) Simultaneous measurement of ERalpha, HER2, and phosphoERK1/2 in breast cancer cell lines by flow cytometry. Breast Cancer Res Treat 129:623–628PubMedCrossRef Bayraktar UD, Kim TK, Drews-Elger K, Benjamin C, El-Ashry D, Wieder E et al (2011) Simultaneous measurement of ERalpha, HER2, and phosphoERK1/2 in breast cancer cell lines by flow cytometry. Breast Cancer Res Treat 129:623–628PubMedCrossRef
9.
go back to reference Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A (2005) PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120:303–313PubMedCrossRef Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A (2005) PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120:303–313PubMedCrossRef
10.
12.
go back to reference Cailleau R, Young R, Olive M, Reeves WJ Jr (1974) Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53:661–674PubMed Cailleau R, Young R, Olive M, Reeves WJ Jr (1974) Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53:661–674PubMed
13.
go back to reference Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F et al (2007) The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 13:2329–2334PubMedCrossRef Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F et al (2007) The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 13:2329–2334PubMedCrossRef
14.
go back to reference Cheang MC, Voduc KD, Tu D, Jiang S, Leung S, Chia SK et al (2012) Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial. Clin Cancer Res 18:2402–2412PubMedCentralPubMedCrossRef Cheang MC, Voduc KD, Tu D, Jiang S, Leung S, Chia SK et al (2012) Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial. Clin Cancer Res 18:2402–2412PubMedCentralPubMedCrossRef
15.
go back to reference Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB et al (2006) Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355:560–569PubMedCrossRef Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB et al (2006) Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355:560–569PubMedCrossRef
17.
go back to reference Francia G, Cruz-Munoz W, Man S, Xu P, Kerbel RS (2011) Mouse models of advanced spontaneous metastasis for experimental therapeutics. Nat Rev Cancer 11:135–141PubMedCrossRef Francia G, Cruz-Munoz W, Man S, Xu P, Kerbel RS (2011) Mouse models of advanced spontaneous metastasis for experimental therapeutics. Nat Rev Cancer 11:135–141PubMedCrossRef
18.
go back to reference Garin-Chesa P, Old LJ, Rettig WJ (1990) Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci USA 87:7235–7239PubMedCentralPubMedCrossRef Garin-Chesa P, Old LJ, Rettig WJ (1990) Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci USA 87:7235–7239PubMedCentralPubMedCrossRef
19.
go back to reference Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21:309–322PubMedCrossRef Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21:309–322PubMedCrossRef
20.
21.
go back to reference Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z et al (2007) Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8:R76PubMedCentralPubMedCrossRef Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z et al (2007) Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8:R76PubMedCentralPubMedCrossRef
22.
go back to reference Hess KR, Pusztai L, Buzdar AU, Hortobagyi GN (2003) Estrogen receptors and distinct patterns of breast cancer relapse. Breast Cancer Res Treat 78:105–118PubMedCrossRef Hess KR, Pusztai L, Buzdar AU, Hortobagyi GN (2003) Estrogen receptors and distinct patterns of breast cancer relapse. Breast Cancer Res Treat 78:105–118PubMedCrossRef
23.
go back to reference Honeth G, Bendahl PO, Ringner M, Saal LH, Gruvberger-Saal SK, Lovgren K et al (2008) The CD44+/CD24− phenotype is enriched in basal-like breast tumors. Breast Cancer Res 10:R53PubMedCentralPubMedCrossRef Honeth G, Bendahl PO, Ringner M, Saal LH, Gruvberger-Saal SK, Lovgren K et al (2008) The CD44+/CD24 phenotype is enriched in basal-like breast tumors. Breast Cancer Res 10:R53PubMedCentralPubMedCrossRef
24.
go back to reference Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF et al (2006) The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genom 7:96CrossRef Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF et al (2006) The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genom 7:96CrossRef
25.
go back to reference Ikeda Y, Hayashi I, Kamoshita E, Yamazaki A, Endo H, Ishihara K et al (2004) Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth. Cancer Res 64:5178–5185PubMedCrossRef Ikeda Y, Hayashi I, Kamoshita E, Yamazaki A, Endo H, Ishihara K et al (2004) Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth. Cancer Res 64:5178–5185PubMedCrossRef
26.
go back to reference Iorns E, Drews-Elger K, Ward TM, Dean S, Clarke J, Berry D et al (2012) A new mouse model for the study of human breast cancer metastasis. PLoS ONE 7:e47995PubMedCentralPubMedCrossRef Iorns E, Drews-Elger K, Ward TM, Dean S, Clarke J, Berry D et al (2012) A new mouse model for the study of human breast cancer metastasis. PLoS ONE 7:e47995PubMedCentralPubMedCrossRef
27.
go back to reference Jeong H, Ryu YJ, An J, Lee Y, Kim A (2012) Epithelial–mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype. Histopathology 60:E87–E95PubMedCrossRef Jeong H, Ryu YJ, An J, Lee Y, Kim A (2012) Epithelial–mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype. Histopathology 60:E87–E95PubMedCrossRef
28.
go back to reference Jessani N, Humphrey M, McDonald WH, Niessen S, Masuda K, Gangadharan B et al (2004) Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo. Proc Natl Acad Sci USA 101:13756–13761PubMedCentralPubMedCrossRef Jessani N, Humphrey M, McDonald WH, Niessen S, Masuda K, Gangadharan B et al (2004) Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo. Proc Natl Acad Sci USA 101:13756–13761PubMedCentralPubMedCrossRef
30.
go back to reference Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J et al (2009) Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS ONE 4:e6146PubMedCentralPubMedCrossRef Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J et al (2009) Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS ONE 4:e6146PubMedCentralPubMedCrossRef
31.
go back to reference Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW et al (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557–563PubMedCrossRef Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW et al (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557–563PubMedCrossRef
32.
go back to reference Kokkinos MI, Wafai R, Wong MK, Newgreen DF, Thompson EW, Waltham M (2007) Vimentin and epithelial–mesenchymal transition in human breast cancer—observations in vitro and in vivo. Cells Tissues Organs 185:191–203PubMedCrossRef Kokkinos MI, Wafai R, Wong MK, Newgreen DF, Thompson EW, Waltham M (2007) Vimentin and epithelial–mesenchymal transition in human breast cancer—observations in vitro and in vivo. Cells Tissues Organs 185:191–203PubMedCrossRef
33.
go back to reference Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L et al (2004) Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 101:4966–4971PubMedCentralPubMedCrossRef Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L et al (2004) Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 101:4966–4971PubMedCentralPubMedCrossRef
34.
35.
go back to reference Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M et al (2005) Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 115:44–55PubMedCentralPubMedCrossRef Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M et al (2005) Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 115:44–55PubMedCentralPubMedCrossRef
36.
go back to reference Minn AJ, Gupta GP, Padua D, Bos P, Nguyen DX, Nuyten D et al (2007) Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci USA 104:6740–6745PubMedCentralPubMedCrossRef Minn AJ, Gupta GP, Padua D, Bos P, Nguyen DX, Nuyten D et al (2007) Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci USA 104:6740–6745PubMedCentralPubMedCrossRef
37.
go back to reference Mueller MM, Fusenig NE (2004) Friends or foes—bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4:839–849PubMedCrossRef Mueller MM, Fusenig NE (2004) Friends or foes—bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4:839–849PubMedCrossRef
38.
go back to reference Nanni P, Nicoletti G, Palladini A, Croci S, Murgo A, Ianzano ML et al (2012) Multiorgan metastasis of human HER-2+ breast cancer in Rag2−/−; Il2rg−/− mice and treatment with PI3K inhibitor. PLoS ONE 7:e39626PubMedCentralPubMedCrossRef Nanni P, Nicoletti G, Palladini A, Croci S, Murgo A, Ianzano ML et al (2012) Multiorgan metastasis of human HER-2+ breast cancer in Rag2−/−; Il2rg−/− mice and treatment with PI3K inhibitor. PLoS ONE 7:e39626PubMedCentralPubMedCrossRef
39.
go back to reference Orimo A, Weinberg RA (2006) Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5:1597–1601PubMedCrossRef Orimo A, Weinberg RA (2006) Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5:1597–1601PubMedCrossRef
40.
go back to reference Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R et al (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335–348PubMedCrossRef Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R et al (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335–348PubMedCrossRef
41.
go back to reference O’Toole SA, Beith JM, Millar EK, West R, McLean A, Cazet A et al (2013) Therapeutic targets in triple negative breast cancer. J Clin Pathol 66:530–542PubMedCrossRef O’Toole SA, Beith JM, Millar EK, West R, McLean A, Cazet A et al (2013) Therapeutic targets in triple negative breast cancer. J Clin Pathol 66:530–542PubMedCrossRef
42.
go back to reference Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T et al (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 27:1160–1167PubMedCentralPubMedCrossRef Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T et al (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 27:1160–1167PubMedCentralPubMedCrossRef
43.
go back to reference Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752PubMedCrossRef Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752PubMedCrossRef
44.
go back to reference Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI et al (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12:R68PubMedCentralPubMedCrossRef Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI et al (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12:R68PubMedCentralPubMedCrossRef
45.
go back to reference Price JE, Polyzos A, Zhang RD, Daniels LM (1990) Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 50:717–721PubMed Price JE, Polyzos A, Zhang RD, Daniels LM (1990) Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 50:717–721PubMed
46.
47.
go back to reference R-Core-Team (2013) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna R-Core-Team (2013) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
48.
go back to reference Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K et al (2005) Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11:5678–5685PubMedCrossRef Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K et al (2005) Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11:5678–5685PubMedCrossRef
49.
go back to reference Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J (2008) Epithelial–mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 68:989–997PubMedCrossRef Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J (2008) Epithelial–mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 68:989–997PubMedCrossRef
50.
go back to reference Shekhar MP, Santner S, Carolin KA, Tait L (2007) Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity. Am J Pathol 170:1546–1560PubMedCentralPubMedCrossRef Shekhar MP, Santner S, Carolin KA, Tait L (2007) Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity. Am J Pathol 170:1546–1560PubMedCentralPubMedCrossRef
51.
52.
go back to reference Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874PubMedCentralPubMedCrossRef Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874PubMedCentralPubMedCrossRef
53.
go back to reference Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418–8423PubMedCentralPubMedCrossRef Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418–8423PubMedCentralPubMedCrossRef
54.
go back to reference Spaeth EL, Labaff AM, Toole BP, Klopp A, Andreeff M, Marini FC (2013) Mesenchymal CD44 expression contributes to the acquisition of an activated fibroblast phenotype via TWIST activation in the tumor microenvironment. Cancer Res 73:5347–5359PubMedCrossRef Spaeth EL, Labaff AM, Toole BP, Klopp A, Andreeff M, Marini FC (2013) Mesenchymal CD44 expression contributes to the acquisition of an activated fibroblast phenotype via TWIST activation in the tumor microenvironment. Cancer Res 73:5347–5359PubMedCrossRef
55.
go back to reference Speirs V, Green AR, Walton DS, Kerin MJ, Fox JN, Carleton PJ et al (1998) Short-term primary culture of epithelial cells derived from human breast tumours. Br J Cancer 78:1421–1429PubMedCentralPubMedCrossRef Speirs V, Green AR, Walton DS, Kerin MJ, Fox JN, Carleton PJ et al (1998) Short-term primary culture of epithelial cells derived from human breast tumours. Br J Cancer 78:1421–1429PubMedCentralPubMedCrossRef
56.
go back to reference Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW et al (1999) The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98:137–146PubMedCentralPubMedCrossRef Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW et al (1999) The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98:137–146PubMedCentralPubMedCrossRef
57.
go back to reference Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J et al (2012) Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 487:500–504PubMedCentralPubMedCrossRef Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J et al (2012) Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 487:500–504PubMedCentralPubMedCrossRef
59.
go back to reference Weigelt B, Peterse JL, van’t Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5:591–602PubMedCrossRef Weigelt B, Peterse JL, van’t Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5:591–602PubMedCrossRef
Metadata
Title
Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures
Authors
Katherine Drews-Elger
Joeli A. Brinkman
Philip Miller
Sanket H. Shah
J. Chuck Harrell
Thiago G. da Silva
Zheng Ao
Amy Schlater
Diana J. Azzam
Kathleen Diehl
Dafydd Thomas
Joyce M. Slingerland
Charles M. Perou
Marc E. Lippman
Dorraya El-Ashry
Publication date
01-04-2014
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2014
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-2887-9

Other articles of this Issue 3/2014

Breast Cancer Research and Treatment 3/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine